| Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma T Bald, T Quast, J Landsberg, M Rogava, N Glodde, D Lopez-Ramos, ... Nature 507 (7490), 109-113, 2014 | 545 | 2014 |
| Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation J Landsberg, J Kohlmeyer, M Renn, T Bald, M Rogava, M Cron, M Fatho, ... Nature 490 (7420), 412-416, 2012 | 513 | 2012 |
| Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy N Glodde, T Bald, D van den Boorn-Konijnenberg, K Nakamura, ... Immunity 47 (4), 789-802. e9, 2017 | 180 | 2017 |
| A molecular single-cell lung atlas of lethal COVID-19 JC Melms, J Biermann, H Huang, Y Wang, A Nair, S Tagore, I Katsyv, ... Nature 595 (7865), 114-119, 2021 | 145 | 2021 |
| A single-cell landscape of high-grade serous ovarian cancer B Izar, I Tirosh, EH Stover, I Wakiro, MS Cuoco, I Alter, C Rodman, ... Nature Medicine 26 (8), 1271-1279, 2020 | 137 | 2020 |
| A stochastic model for immunotherapy of cancer M Baar, L Coquille, H Mayer, M Hölzel, M Rogava, T Tüting, A Bovier Scientific reports 6 (1), 1-10, 2016 | 47 | 2016 |
| Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion CJ Frangieh, JC Melms, PI Thakore, KR Geiger-Schuller, P Ho, ... Nature genetics 53 (3), 332-341, 2021 | 46 | 2021 |
| A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast CellsMelanoma Phenotype–Dependent Mast Cell Recruitment M Hölzel, J Landsberg, N Glodde, T Bald, M Rogava, S Riesenberg, ... Cancer research 76 (2), 251-263, 2016 | 27 | 2016 |
| Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor ActivityTargeting Haspin for Cancer Therapy JC Melms, S Vallabhaneni, CE Mills, C Yapp, JY Chen, E Morelli, ... Cancer research 80 (4), 798-810, 2020 | 17 | 2020 |
| A stochastic individual-based model for immunotherapy of cancer M Baar, L Coquille, H Mayer, M Hölzel, M Rogava, T Tüting, A Bovier arXiv preprint arXiv:1505.00452, 2015 | 3 | 2015 |
| The CD58: CD2 axis is co-regulated with PD-L1 via CMTM6 and governs anti-tumor immunity P Ho, JC Melms, M Rogava, CJ Frangieh, SB Shah, Z Walsh, O Kyrysyuk, ... bioRxiv, 2022 | 2 | 2022 |
| Tumor cell intrinsic Toll‐like receptor 4 signaling promotes melanoma progression and metastatic dissemination M Rogava, AD Braun, TC van der Sluis, N Shridhar, T Tüting, E Gaffal International Journal of Cancer 150 (1), 142-151, 2022 | 2 | 2022 |
| CXCR3: Here to stay to enhance cancer immunotherapy? M Rogava, B Izar EBioMedicine 49, 11-12, 2019 | 2 | 2019 |
| Dissecting the treatment-naive ecosystem of human melanoma brain metastasis J Biermann, JC Melms, AD Amin, Y Wang, LA Caprio, A Karz, S Tagore, ... Cell 185 (14), 2591-2608. e30, 2022 | 1 | 2022 |
| The myeloid cell type I IFN system promotes antitumor immunity over pro‐tumoral inflammation in cancer T‐cell therapy J Ruotsalainen, D Lopez‐Ramos, M Rogava, N Shridhar, N Glodde, ... Clinical & Translational Immunology 10 (4), e1276, 2021 | 1 | 2021 |
| A genetic-metabolic axis of metastatic liver organotropism M Rogava, JC Melms, S Davis, C Hug, B Ngo, MJ Lee, P Ho, AD Amin, ... Cancer Research 82 (12_Supplement), 981-981, 2022 | | 2022 |
| Dissecting the ecosystem of treatment-naïve melanoma brain metastasis using multi-modal single-cell analysis JC Melms, J Biermann, AD Amin, Y Wang, S Tagore, M Andreatta, A Nair, ... Cancer Research 82 (12_Supplement), 984-984, 2022 | | 2022 |
| CD58: CD2-a multi-dimensional axis in cancer immunotherapy resistance P Ho, J Melms, M Rogava, S Shah, B Izar Cancer Research 82 (12_Supplement), 2165-2165, 2022 | | 2022 |
| Tumor cell intrinsic TLR4 signaling promotes melanoma progression and metastatic dissemination. M Rogava, AD Braun, TC van der Sluis, N Shridhar, T Tüting, E Gaffal International Journal of Cancer, 2021 | | 2021 |
| Development of antigen specific immunotherapy against melanoma with TRP1 targeted CD4 (+) T cell transfer. N Shridhar, TC van der Sluis, J Ruotsalainen, B Kruse, S Bonifatius, ... EXPERIMENTAL DERMATOLOGY 28 (3), E54-E54, 2019 | | 2019 |
Thomas TütingDepartment of Dermatology, University Hospital Magdeburg, GermanyVerified email at med.ovgu.de
